Conclusion La relation possible entre la neurotoxiciteĺ ie´e à l'anesthe´sie, le dysfonctionnement cognitif postope´ratoire et la MA reste a`e´tablir clairement. Al 'heure actuelle, il est difficile de de´terminer si le de´clin cognitif postope´ratoire chez le patient aˆge´n'est pas davantage lie´au stress pe´riope´ratoire et aux comorbidite´s me´dicales associe´es qu'a`l'anesthe´sie.
Due to their lipid solubility, general anesthetics enter the brain readily in high concentrations, dissolving into cellular membranes, penetrating organelle, and acting on multiple receptors, ion channels, second messenger systems, and cytoskeletal components. 1 Until recently, it has been assumed that these effects are reversible and nontoxic. However, a growing body of laboratory evidence suggests that general anesthetics may be neurotoxic to both young and aging brains. The evidence comes from in vitro and in vivo studies with cells, rodents, and nonhuman primates. 2 Postoperative cognitive decline in the elderly has emerged as a major health concern. 3 In addition, there is a growing interest in the potential relationship between general anesthetic exposure and the onset and progression of Alzheimer's disease (AD). 4 In this review, we focus on the recent studies of anesthesia-induced neurotoxicity, while highlighting the limitations of existing data, and we put the literature into perspective for the clinician. Although this review focuses primarily on studies of anesthesia-induced neurotoxicity, it must be emphasized that many other studies have shown that anesthetics do not induce toxic effects; furthermore, some anesthetics have been reported to have organ (e.g., heart and brain) protective effects. Since anesthesiainduced protective effects are beyond the scope of this manuscript, we do not describe other deserving research results in this focused review.
Anesthetic neurotoxicity
Neurotoxicity is defined as structural or functional alteration in the nervous system resulting from exposure to a chemical, biological, or physical agent. 5 The brain is especially vulnerable to the effects of neurotoxins at the extremes of age. The aged brain suffers from loss of neurons, reduced rates of neurogenesis, and synaptogenesis and accumulation of potentially toxic byproducts. Thus, reduced reserve and increased vulnerability lead to functional impairment from neural insults, such as oxidative stress or toxin exposure. Current hypotheses attribute the neurotoxic effects of volatile anesthetics to direct toxic effects (e.g., via altered calcium homeostasis), 6 enhancement of endogenous neurodegenerative mechanisms (e.g., increased production of Ab), 7 neuroinflammation triggered by surgically-induced systemic inflammation, 8 or age-sensitive suppression of stem cell proliferation or differentiation. 9 The study of neurotoxic effects of anesthetics in humans is limited by a number of factors, including difficulty in obtaining tissue for histological study and the confounding effects of surgery and associated diseases. To complicate matters, anesthetics may have neuroprotective effects depending on the drug, dose, and duration of exposure. [10] [11] [12] [13] [14] There are a number of reasons for the delayed appreciation of the potential association between anesthetics and neurodegeneration, including the slowly progressive nature of neurodegenerative disease, limited follow-up by surgeons and anesthesiologists, presence of confounding factors, such as coincident illness, and the social stigma of the disease.
Cognitive dysfunction in the elderly
Alzheimer's disease Alzheimer's disease is a neurodegenerative disease. It is the most common form of dementia in adults, affecting 35 million people worldwide and 5.3 million people in the United States alone. 15 Alzheimer's disease is associated with significant morbidity and mortality and leads to death within three to nine years after diagnosis. 15 Furthermore, AD has a major social and economic impact, since the people affected not only lose their own productivity and independence but also require continual one-on-one care. Clinically, AD typically presents with subtle onset of memory loss followed by a slowly progressive dementia over a course of several years.
Pathologically, the brains of AD patients have gross diffuse atrophy of the cerebral cortex with the secondary enlargement of the ventricular system. Cerebral plaques laden with b-amyloid peptides are a pathologic feature of AD. The peptides coalesce into intermediate assemblies, or they can arrange themselves into sheets of b-amyloid (Ab) fibrils that can form advanced amyloid plaques. This excess accumulation of Ab may be the initiating factor in AD (''amyloid hypothesis''). 16 Like Ab, abnormal tau molecules are cytotoxic and contribute to dementia. Abnormal tau and Ab appear to contribute to synaptic loss and dysfunction even before tangles and plaques are detected. 17, 18 In addition, a number of molecular lesions have been identified in AD, with most centering on a few cellular pathways. Common themes include accumulation of abnormal proteins resulting in inflammatory and oxidative damage and ultimately resulting in synaptic loss.
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The principal risk factor for AD is age. A number of etiologic factors have been proposed to contribute to the neuropathogenesis of AD, including genetic susceptibility, metabolic alterations, and environmental exposures. Identification of several AD associated genes has provided a foundation for understanding the pathogenesis of AD. However, the majority of cases are sporadic in origin, and the exact causes of sporadic AD are unknown.
Postoperative cognitive dysfunction
Many elderly patients experience difficulties with memory, concentration and attention after surgery and anesthesia, which is referred to as postoperative cognitive dysfunction (POCD). These cognitive changes are usually short-lived with normal function returning within a few days, but changes may persist for weeks or more. POCD is often mild and only detected by neuropsychological testing after anesthesia and surgery. In the extreme, it may manifest clinically as memory loss, impaired higher level cognitive function, psychomotor derangement, difficulties with fine motor coordination, dementia, delirium, or depression. 19 Postoperative cognitive dysfunction has been associated with leaving the labour market prematurely, increased dependency on social support, and increased mortality. 20 The incidence of POCD after noncardiac surgery has been reported to be as high as 26% at one week, 10% at three months, 21 5% at six months, and 1% at 12 months after surgery. 22 However, the incidence of POCD after cardiac surgery can be as high as 53%, 36%, 24%, and 42% at discharge, six weeks, six months, and five years, respectively, after surgery. 23 It should be emphasized that the definition of POCD is still in evolution 24 ; therefore, the difference in POCD incidence in these studies might be due to different criteria used in determining POCD.
The mechanism of POCD is unclear. However, since Ab is a peptide naturally present in the central nervous system, with higher levels in the elderly, there has been speculation that these higher amounts of Ab in the aging brain are available to interact with general anesthetics and other perioperative factors leading to deleterious effects on the brain and increasing the risk for POCD.
Evidence for anesthesia-mediated neurodegeneration
Cell and tissue culture Inhaled anesthetics have been shown to induce damage in a variety of tissues and cells, including hippocampal slices, neuroglioma cells, and primary cortical and striatal neurons. The various in vitro models have shown different toxicity to inhaled anesthetics. Cells transfected with genes associated with AD have been shown to be more sensitive to anesthetic toxicity. 25 As recently reviewed in Tang et al., in vitro studies using isolated proteins, cells in culture, and brain slices have provided evidence that the inhaled anesthetics may produce effects consistent with increased cellular stress through recognized pathways of neurodegeneration 2 Most of this work has been done with the commonly used inhalation anesthetics, isoflurane, sevoflurane, and desflurane. Isoflurane, [26] [27] [28] sevoflurane, 29 desflurane plus hypoxia, 30 and isoflurane plus nitrous oxide 31 have been shown to induce cellular apoptosis and increase Ab generation. It is important to note that most of these studies were performed with tumour cells rather than with primary neurons.
Animal models
Animal models allow the exploration of mechanisms by which anesthetics may induce AD pathogenesis as well as provide a way to examine the effects of anesthesia and surgery independently. Several studies from animal models suggest that anesthetic exposure impairs cognitive function and increases pathology commonly associated with AD. In adult wild-type rats and mice, exposure to isoflurane can result in decrements in learning that persists for weeks or months. [32] [33] [34] [35] Furthermore, in the elderly rodent, exposure to isoflurane, nitrous oxide, or the combination of isofluranenitrous oxide can cause persistent memory impairment. [32] [33] [34] [35] [36] Anesthesia with 1.4% isoflurane 28 or 2.5% sevoflurane 29 for two hours has been shown to induce caspase-3 activation and increase Ab levels in brain tissues of five-month-old wildtype mice. It should be noted that these animals received isoflurane or sevoflurane plus 100% oxygen. Therefore, the possibility cannot be excluded that the combination of anesthetics and high oxygen concentrations induces neurotoxicity rather than anesthetic agents alone. These studies did not assess the potential impairment of cognitive function associated with the biochemical changes.
A recent study reported that anesthesia with 2.1% sevoflurane for six hours can induce caspase-3 activation and increase Ab levels in the brain tissues of neonatal mice (6 days old) and AD transgenic mice. 37 Furthermore, the sevoflurane anesthesia led to a greater degree of neurotoxicity in the brain tissues of the AD transgenic mice when compared with neonatal mice with increased tumor necrosis factor-alpha levels in the brain tissues of the AD transgenic mice. Early studies have shown that hypothermia 38 and anesthesia 39 can induce tau hyperphosphorylation. In the transgenic mouse models of AD, increased Ab plaque loads and tau aggregation have been demonstrated after halothane and isoflurane exposure, respectively. 25 In a mouse model, Run et al. found that anesthesia, even for short periods of time (30 sec to five minutes), resulted in tau phosphorylation in specific AD-related hyperphosphorylation sites. 40 Other studies have suggested that the link between inhaled anesthetics and neurodegenerative changes is dose and context specific. In a study to investigate the effects of repeated isoflurane exposure (35 min daily for four days) on juvenile and mature rodents, Zhu et al. found that recognition and reversal learning were impaired in the young rodents, and these deficits became more pronounced as the animals grew older. 41 The memory deficit was paralleled by a reduction in the hippocampal stem cell pool and reduced neurogenesis. Interestingly, the mature animals were unaffected by the isoflurane exposure. In another laboratory, Stratmann et al. examined hippocampal progenitor proliferation, neuronal lineage selection and survival, as well as learning and spatial memory acquisition in seven-day-old and 60-day-old rats. The authors found a delayed onset, progressive and persistent deficit in memory tasks in the seven-day-old rats, whereas the 60-day-old rats showed improvement in spatial reference memory. Furthermore, there was an isoflurane-induced decrease in neuronal progenitor proliferation in the seven-day-old rats and an increase in neuronal differentiation in the 60-dayold rats. 42 In another study, the same group of investigators examined aged rats exposed to one minimum alveolar concentration of isoflurane for four hours. The investigators failed to detect a difference in hippocampal progenitor proliferation or in neuronal survival compared with agematched controls. In addition, no difference was found in associative learning, spatial memory acquisition, or retention four months after isoflurane exposure. 43 Given these conflicting results, it remains unclear as to the conditions under which volatile anesthetic exposure results in neurodegenerative changes and cognitive impairment. Although animal models have provided some insight into the mechanisms of neuronal loss and accumulation of neurotoxic proteins, the connection between these lesions, symptoms, and causes of the disease remains difficult to unravel. A causal link between anestheticinduced biochemical markers of neurotoxicity and the development of long-term cognitive dysfunction is required to solidify the proposed link between inhaled anesthetics and neurodegenerative changes.
Surgery itself may be a risk factor for cognitive dysfunction. Wan et al. subjected anesthetized rats to splenectomy vs no surgery and demonstrated that there was a period of cognitive dysfunction in the splenectomized rats, as assessed by performance in a Y-maze, which was associated with biochemical markers of hippocampal glial cell activation and inflammation. 8 In another recent study, Wan et al. showed that partial hepatectomy under general anesthesia in 16-month-old mice induced learning and memory impairment as demonstrated by Morris Water Maze performance as well as gliosis, Ab accumulation, and tau protein phosphorylation as compared with anesthetized controls. 44 Interestingly, the anesthetized rats and mice in these studies that did not undergo surgery showed none of the changes in maze performance or inflammatory markers, suggesting that observed changes were not related to anesthesia alone. In addition, the anesthesia used in these studies was fentanyl plus droperidol 8 and chloral hydrate. 44 Therefore, it remains to be determined whether the volatile anesthetics (e.g., isoflurane) that have been shown to induce apoptosis, Ab accumulation, and tau phosphorylation can lead to learning and memory impairment in the same rodent model of surgery vs no surgery. Given that surgery without general anesthesia can also cause POCD in humans, 45, 46 it is important to determine the effects of surgery without general anesthesia on the cognitive changes.
Evidence for an association between volatile anesthetic exposure and neurotoxicity in humans
Despite the animal data suggesting a relationship between anesthesia and AD neuropathogenesis, a definitive link remains elusive in humans. Several small human studies have examined the link between anesthesia, surgery, and AD with conflicting results. A case control study by Gasparini et al. found no association between AD and exposure to anesthesia in the one to five years preceding disease onset, nor between the risk of AD and the number of surgical operations. 47 Similarly, Bohnen et al. found no significant difference in mean cumulative duration of exposure to general anesthesia and increased risk of AD. 48 However in another retrospective study, Bohnen et al. found an inverse relationship between age of onset of AD and cumulative anesthesia exposure before the age of 50, which suggests that the manifestation of dementia in AD patients may be related to anesthetic exposure at an earlier age. 49 In a cohort analysis of patients undergoing coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA), an increased risk for emergence of AD was found in patients undergoing CABG, suggesting that cardiac surgery and anesthesia may be associated with long-term cognitive effects in an aging population with reduced neuronal reserve. 50 Cognitive dysfunction is well-documented after cardiac surgery, and cardiopulmonary bypass has been implicated as a risk factor for cognitive decline and dementia. 51 However, even in this patient population, the results are contradictory. In a population-based case-control study, Knopman et al. found no association between CABG and risk for dementia. 52 In patients undergoing cardiac surgery, multiple risk factors have been implicated in the development of POCD, including hypoperfusion, cerebral Anesthesia neurotoxicity 219 embolism, atrial fibrillation, myocardial ischemia, systemic inflammatory response, and pre-existing cerebral injury or cognitive impairment. These differing cited causes could predispose or exacerbate vulnerability to cognitive impairment without invoking anesthetic neurotoxicity as a culprit. A recent study examining the impact of non-cardiac surgery, illness, or neither on cognitive decline in the elderly did not detect long-term cognitive decline independently attributable to surgery or illness, nor were these events associated with decline to dementia, although demented patients declined more markedly than nondemented patients. 53 However, as with all other retrospective studies, this study has several limitations, including difficulty in finding appropriate controls, as described in the manuscript.
A growing body of literature describes an association between critical illness and cognitive impairment. [54] [55] [56] In a recent cohort study of older adults without dementia at baseline, Ehlenbach et al. found that those who were hospitalized for acute care or critical illness had a greater likelihood of cognitive decline compared with those who were not hospitalized. 57 Furthermore, hospitalization for noncritical illness was also significantly associated with the development of dementia. The findings from these studies strongly suggest the need for adequately powered multicentre clinical trials to define in further detail the interplay of anesthesia, surgery, and intercurrent illness on the development of cognitive dysfunction in the elderly.
Do we need to change clinical practice?
The available evidence suggests a possible association between anesthesia, surgery, and long-term cognitive effects, including AD. Nevertheless, it is premature to alter clinical practice because three issues have not been evaluated rigorously in clinical trials. To date, no study has shown that general anesthetics administered at clinically relevant doses and for clinically relevant durations cause neurotoxicity in humans. There is no scientific basis for either recommending or contraindicating specific anesthetic agents or techniques on the basis of neurotoxicity or risk of cognitive morbidity in the elderly. 58 It is essential to bear in mind that the overriding goals of anesthesia are to ensure patient comfort, patient safety, and optimal conditions for surgery. We should not compromise the well-established benefits of general anesthesia because of some early laboratory results without substantiated clinical relevance.
So what steps should the clinician consider? It seems rational to minimize the complexity of anesthetic regimens and to use the lowest reasonable effective doses and concentrations of anesthetic required according to individual patient needs, the varying levels of surgical stimulation, and postoperative analgesic requirements. However, this may be difficult, since the minimal alveolar concentration values for animal models of AD are increased relative to their non-AD counterparts. 59, 60 Although a recent study did not find an association between depth of anesthesia and development of POCD, 61 further research is certainly needed. Use of regional anesthesia instead of general anesthesia has been suggested to avoid volatile anesthetic exposure. However, there is no solid evidence to show that the incidence of POCD is different after general anesthesia as compared with regional anesthesia. 62 Rank ordering for amyloidogenic potential and cytotoxicity has been reported for inhalational anesthetics in cell culture. 26, 63 Isoflurane has greater potency than either sevoflurane or desflurane to cause calcium release from the endoplasmic reticulum and to induce cell damage. However, a recent randomized trial comparing desflurane with sevoflurane in elderly patients found no difference in the incidence of POCD, although performances in several cognitive tests favoured desflurane. 64 Although tempting to favour the use of the shorter-acting volatile anesthetics for this reason, the literature does not allow definitive conclusions to be drawn at this time. Hypothermia causes tau hyperphosphorylation and associated memory impairment in animals. 38, 65 Given the involvement of tau hyperphosphorylation in AD, it provides another reason to ensure normothermia in the perioperative period.
Areas for further study
Given the available evidence, a possible association between anesthesia, surgery, and long-term cognitive effects, including AD, needs to be taken seriously. There is a great need for further well-designed adequately powered randomized trials and observational studies to assess the impact of anesthetic exposure on cognitive decline. Since surgery itself may be a contributing factor, the need for human studies evaluating anesthesia exposure in the absence of surgery would be particularly informative.
There are five key questions that should direct research efforts: Interrogating large pre-existing databases with many years of individual patient data (e.g., Veterans Affairs Medicare) seems like the most rapid and risk-free way of examining the association between anesthesia, surgery, and postoperative cognitive decline. Biomarkers derived from structural and functional neuroimaging studies and those measured in cerebrospinal fluid, show great promise for identifying preclinical pathology and for monitoring change over time and after anesthetic exposure. 66, 67 Since adequately powered clinical trials examining these questions will require many years to conduct and to analyze, there is an immediate need for further animal studies to define the effects of both anesthesia and surgery on the pathogenesis of AD. These studies will complement ongoing clinical trials by establishing mechanistic hypotheses, vulnerable windows, and less provocative anesthetics.
In summary, it will take time to examine the potential link between the laboratory findings suggesting anestheticinduced neurotoxicity and adverse clinical outcomes. The possible relation between anesthetic neurotoxicity, POCD, and AD remains elusive. It remains unclear whether postoperative cognitive decline is related more to perioperative stress and the presence of patient-associated co-morbidities than to the effects of anesthetic exposure. It is important that the perioperative physician is aware of the potential link between anesthesia, surgery, and cognitive decline in the elderly, because the perioperative setting provides a unique opportunity to evaluate pre-emptive therapies. As clinicians, it is important that we remain abreast of the ongoing research in this important field of investigation.
Funding sources Several studies referenced in this review were supported by National Institutes of Health grants (Bethesda, Maryland) (K08 NS048140, R21 AG029856, and R01 GM088801); American Geriatrics Society Jahnigen Award (New York, NY); Investigator-Initiated Research Grant from Alzheimer's Association (Chicago, IL) to Dr. Zhongcong Xie.
Competing interests None declared.
